Compared to the normal cerebellum, the expression level of miR-192 in medulloblastoma cells is lower, and studies indicated that miR-192 suppresses the expressions of ITGAV, ITGB1, ITGB3, and CD47 in medulloblastoma (28). Here, CD47 is linked to medulloblastoma.